ESR1 and breast cancer: Almost at the same time, DHS was synthesized andidentified as specific estrogen receptor (ER)-ligand18, and later, as anERα antagonist by inducing slow and selective proteasome-independentdown-regulation of the receptor in two estrogen-sensitive breast cancer cell lines19.